Top compounds associated with response to PRRG2


Feature Type Standardized
Nominal ANOVA
mRNA neratinib CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA lovastatin CTRPv2 pan-cancer AAC -0.19 2e-05
mRNA lapatinib gCSI pan-cancer AAC 0.26 3e-05
mRNA paclitaxel gCSI pan-cancer AAC -0.25 4e-05
mRNA STF-31 CTRPv2 pan-cancer AAC -0.17 4e-05
mRNA GSK429286A GDSC1000 pan-cancer AAC -0.15 6e-05
mRNA BIBW2992 CTRPv2 pan-cancer AAC 0.18 6e-05
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.23 7e-05
mRNA niclosamide CTRPv2 pan-cancer AAC -0.17 0.0001
mRNA FK866 GDSC1000 pan-cancer AAC -0.14 0.0001
Download CSV